Acute severe asthma: Triage, treatment and thereafter

Current Anaesthesia and Critical Care

Volumn 18, Issue 2, 2007, Pages 61-68

  Chua, Felix ^a   Lai, Dilys ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Acute severe asthma; Bronchodilators; Corticosteroids; Life threatening

Indexed keywords

ADRENALIN; AMINOPHYLLINE; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; HELIOX; HYDROCORTISONE; INFUSION FLUID; IPRATROPIUM BROMIDE; KETAMINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; MAGNESIUM SULFATE; METHYLPREDNISOLONE; MONTELUKAST; OXYGEN; PREDNISOLONE; SALBUTAMOL; SHORT ACTING DRUG; STEROID; TERBUTALINE; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ACUTE DISEASE; ADRENERGIC SYSTEM; ARTICLE; ASTHMA; ASTHMATIC STATE; CARDIOPULMONARY FUNCTION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSENSUS; CORRELATION ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; EMERGENCY HEALTH SERVICE; HEALTH CARE PLANNING; HEART ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITAL PHYSICIAN; HUMAN; INTENSIVE CARE UNIT; LOADING DRUG DOSE; METERED DOSE INHALER; MONOTHERAPY; MORBIDITY; MORTALITY; OPTIMAL DRUG DOSE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESUSCITATION; RISK ASSESSMENT; SIDE EFFECT; SINGLE DRUG DOSE; SYMPTOMATOLOGY; SYSTEMIC DISEASE; TREATMENT RESPONSE; VOMITING;

EID: 34548364183     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2007.03.008     Document Type: Article

References (57)

1. Hospital Episode Statistics, Department of Health. 〈www.hesonline.nhs.uk〉; 2005 [accessed September 2006].
2. Office for National Statistics. Mortality statistics by cause. Series DH2, no. 31. The London: Stationery Office; 2005.
3. American Lung Association. Trends in asthma morbidity and mortality. Epidemiology and Statistics Unit, Research and Program Services. 〈http://www.lungusa.org〉; July 2006 [accessed September 2006].
4. Cairns C.B. Acute asthma exacerbations: phenotypes and management. Clin Chest Med 27 1 (2006) 99-108
5. Tattersfield A.E., Postma D.S., Barnes P.J., Svensson K., Bauer C.A., O'Byrne P.M., et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 160 2 (1999) 594-599
6. Djukanovic R. Asthma: a disease of inflammation and repair. J Allergy Clin Immunol 105 2 Pt 2 (2000) S522-S526
7. Lamblin C., Gosset P., Tillie-Leblond I., Saulnier F., Marquette C.H., Wallaert B., et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med 157 2 (1998) 394-402
8. Tillie-Leblond I., Pugin J., Marquette C.H., Lamblin C., Saulnier F., Brichet A., et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 159 2 (1999) 487-494
9. Messer J.W., Peters G.A., and Bennett W.A. Causes of death and pathologic findings in 304 cases of bronchial asthma. Dis Chest 38 (1960) 616-624
10. Nowak R.M., Pensler M.I., Sarkar D.D., Anderson J.A., Kvale P.A., Ortiz A.E., et al. Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma. Ann Emerg Med 11 2 (1982) 64-69
11. Baumann U.A., Haerdi E., and Keller R. Relations between clinical signs and lung function in bronchial asthma: how is acute bronchial obstruction reflected in dyspnoea and wheezing?. Respiration 50 4 (1986) 294-300
12. Wolfenden L.L., Diette G.B., Krishnan J.A., Skinner E.A., Steinwachs D.M., and Wu A.W. Lower physician estimate of underlying asthma severity leads to undertreatment. Arch Intern Med 163 2 (2003) 231-236
13. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 162 6 (2000) 2341-2351
14. Gerdtham U.G., Hertzman P., Jonsson B., and Boman G. Impact of inhaled corticosteroids on acute asthma hospitalization in Sweden 1978 to 1991. Med Care 34 12 (1996) 1188-1198
15. Neffen H., Baena-Cagnani C., Passalacqua G., Canonica G.W., and Rocco D. Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990-1999). Respir Med 100 8 (2006) 1431-1435
16. Awadh N., Chu S., Grunfeld A., Simpson K., and FitzGerald J.M. Comparison of males and females presenting with acute asthma to the emergency department. Respir Med 90 8 (1996) 485-489
17. Gupta D., Keogh B., Chung K.F., Ayres J.G., Harrison D.A., Goldfrad C., et al. Characteristics and outcome for admissions to adult, general critical care units with acute severe asthma: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 8 2 (2004) R112-R121
18. Kearney S.E., Graham D.R., and Atherton S.T. Acute severe asthma treated by mechanical ventilation: a comparison of the changing characteristics over a 17 yr period. Respir Med 92 5 (1998) 716-721
19. McFadden Jr. E.R. Acute severe asthma. Am J Respir Crit Care Med 168 7 (2003) 740-759
20. Braman S.S., and Kaemmerlen J.T. Intensive care of status asthmaticus. A 10-year experience. J Am Med Assoc 264 3 (1990) 366-368
21. Webb A.K., Bilton A.H., and Hanson G.C. Severe bronchial asthma requiring ventilation. A review of 20 cases and advice on management. Postgrad Med J 55 641 (1979) 161-170
22. Bion J. Rationing intensive care. Br Med J 310 6981 (1995) 682-683
23. Crane J., Pearce N., Burgess C., Woodman K., Robson B., and Beasley R. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol 21 4 (1992) 737-744
24. Turner M.O., Noertjojo K., Vedal S., Bai T., Crump S., and Fitzgerald J.M. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med 157 6 Pt 1 (1998) 1804-1809
25. de Klerk A., van Schalkwyk E., Williams Z., Lee W., and Bardin P. Risk factors for near-fatal asthma-a case-control study in a Western Cape teaching hospital. S Afr Med J 92 2 (2002) 140-144
26. Kolbe J., Fergusson W., Vamos M., and Garrett J. Case-control study of severe life threatening asthma (SLTA) in adults: psychological factors. Thorax 57 4 (2002) 317-322
27. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. A national clinical guideline. 〈www.brit-thoracic.org.uk〉; November 2005 [accessed September 2006].
28. National Institutes of Health. Guidelines for the Diagnosis and Management of Asthma, Expert Panel, Report 2. National Heart, Lung and Blood Institute 〈http://www.nhlbi.nih.gov/guidelines/asthma/asthgdin.htm〉; 1997 [accessed October 2006].
29. Martin J.G., Shore S.A., and Engel L.A. Mechanical load and inspiratory muscle action during induced asthma. Am Rev Respir Dis 128 3 (1983) 455-460
30. Summer W., Elston R., Tharpe L., Nelson S., and Haponik E.F. Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care. Arch Intern Med 149 3 (1989) 618-623
31. Bowton D.L., Goldsmith W.M., and Haponik E.F. Substitution of metered-dose inhalers for hand-held nebulizers. Success and cost savings in a large, acute-care hospital. Chest 101 2 (1992) 305-308
32. Rodrigo G.J., and Rodrigo C. Continuous vs intermittent beta-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis. Chest 122 1 (2002) 160-165
33. Travers A.H., Rowe B.H., Barker S., Jones A., and Camargo Jr. C.A. The effectiveness of IV beta-agonists in treating patients with acute asthma in the emergency department: a meta-analysis. Chest 122 4 (2002) 1200-1207
34. Stoodley R.G., Aaron S.D., and Dales R.E. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. Ann Emerg Med 34 1 (1999) 8-18
35. Barnes P.J. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J 19 1 (2002) 182-191
36. Rowe B.H., Spooner C., Ducharme F.M., Bretzlaff J.A., and Bota G.W. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 1 (2001) CD002178
37. Rowe B.H., Spooner C.H., Ducharme F.M., Bretzlaff J.A., and Bota G.W. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst Rev 1 (2001) CD000195
38. Rodrigo G., and Rodrigo C. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med 157 3 Pt 1 (1998) 698-703
39. Edmonds M.L., Camargo Jr. C.A., Pollack Jr. C.V., and Rowe B.H. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 3 (2003) CD002308
40. Iseri L.T., and French J.H. Magnesium: nature's physiologic calcium blocker. Am Heart J 108 1 (1984) 188-193
41. Fawcett W.J., Haxby E.J., and Male D.A. Magnesium: physiology and pharmacology. Br J Anaesth 83 2 (1999) 302-320
42. Noppen M., Vanmaele L., Impens N., and Schandevyl W. Bronchodilating effect of intravenous magnesium sulfate in acute severe bronchial asthma. Chest 97 2 (1990) 373-376
43. Cairns C.B., and Kraft M. Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients. Acad Emerg Med 3 12 (1996) 1093-1097
44. Rowe B.H., Bretzlaff J.A., Bourdon C., Bota G.W., and Camargo Jr. C.A. Intravenous magnesium sulfate treatment for acute asthma in the emergency department: a systematic review of the literature. Ann Emerg Med 36 3 (2000) 181-190
45. Alter H.J., Koepsell T.D., and Hilty W.M. Intravenous magnesium as an adjuvant in acute bronchospasm: a meta-analysis. Ann Emerg Med 36 3 (2000) 191-197
46. Littenberg B. Aminophylline treatment in severe, acute asthma. A meta-analysis. J Am Med Assoc 259 11 (1988) 1678-1684
47. Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev 2000;(4):CD002742.
48. Putland M., Kerr D., and Kelly A.M. Adverse events associated with the use of intravenous epinephrine in emergency department patients presenting with severe asthma. Ann Emerg Med 47 6 (2006) 559-563
49. Rodrigo G.J., Rodrigo C., Pollack C.V., and Rowe B. Use of helium-oxygen mixtures in the treatment of acute asthma: a systematic review. Chest 123 3 (2003) 891-896
50. Sarma V.J. Use of ketamine in acute severe asthma. Acta Anaesthesiol Scand 36 1 (1992) 106-107
51. Petrillo T.M., Fortenberry J.D., Linzer J.F., and Simon H.K. Emergency department use of ketamine in pediatric status asthmaticus. J Asthma 38 8 (2001) 657-664
52. Howton J.C., Rose J., Duffy S., Zoltanski T., and Levitt M.A. Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med 27 2 (1996) 170-175
53. Meduri G.U., Cook T.R., Turner R.E., Cohen M., and Leeper K.V. Noninvasive positive pressure ventilation in status asthmaticus. Chest 110 3 (1996) 767-774
54. Ram F.S., Wellington S., Rowe B., and Wedzicha J.A. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 20 3 (2005) CD004360
55. Soroksky A., Stav D., and Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest 123 4 (2003) 1018-1025
56. McFadden Jr. E.R., Elsanadi N., Dixon L., Takacs M., Deal E.C., Boyd K.K., et al. Protocol therapy for acute asthma: therapeutic benefits and cost savings. Am J Med 99 6 (1995) 651-661
57. McFadden Jr. E.R., Strauss L., Hejal R., Galan G., and Dixon L. Comparison of two dosage regimens of albuterol in acute asthma. Am J Med 105 1 (1998) 12-17